NCT01167153View on ClinicalTrials.gov

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

564

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Hypertension
Interventions
DRUG

Valsartan/Amlodipine

Valsartan/Amlodipine 80/5mg single pill combination (SPC)

DRUG

Nifedipine

Nifedipine GITS (Gastro-Intestinal Therapeutic System ) 30 mg

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Beijing

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY